HOME / Notice / News / EN
GK Global Group Chairman Dong-Hwa Shin attended the Asia Digital Economy Industry Summit (ADES) hosted by Hong Kong's Asian Television (aTV) to meet with the world's top IT industry leaders and he had time to announce the theme. The ADES, held in Hong Kong on September 19, was a summit of digital cur...
NKCL project was introduced in the event held on August 30 in Kuala Lumpur, Malaysia. A Malaysian news agency, BERNAMA and major Chinese media like China Times has covered and broadcasted the event. GK Global Group, parent company of NKCL Bio Group, presented NKCL (Immune Care Platform) project in th...
Immune cell therapy (NK cell) – Fourth-generation anti-cancer treatment Cancer is the biggest cause of death in Korea, and the number of cancer patients constantly increasing every year. Modern cancer treatments generally treat the cancer by three major cancer treatments such as surgery therapy, rad...
[NKCL] NK cell chemotherapy (immune cell therapy) process NK cell chemotherapy (immune cell therapy) process NK cells, which are widely being used as the fourth-generation chemotherapy, have been recognized as advanced medical technology in advanced countries such as the United States and Japan for a...
[NKCL] Diseases that can be treated using NK cells (immune cell therapy) Immunity is the best doctor and treatment -Hippocrates. It was left by Hippocrates, the father of medicine. Immunity is an important system to defend our bodies from external intrusions or internal breakdowns. If there is an imb...